It's all about market potential when investing in biotech start-up stock. Don't forget IMU still have $100M in cash and $35M R&D rebate for this and last financial year and in case you didn't know as a holder, IMU have 2 IP in ph2 with HER-Vaxx completed Ph2 with very good clinical trial results and also Fast track Designation for other IP.
It's all about market potential when investing in biotech...
-
- There are more pages in this discussion • 991 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $404.2M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 17059 | 6.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.3¢ | 2293 | 1 |
View Market Depth
| Last trade - 09.55am 29/07/2024 (20 minute delay) ? |
| IMU (ASX) Chart |
Day chart unavailable